傲农生物：2025年全年净利润同比预减76.70%—84.47%

Core Viewpoint - The company, Aonong Biological, is forecasting a significant decline in net profit for 2025, with an expected range of 90 million to 135 million yuan, representing a year-on-year decrease of 76.70% to 84.47% [1] Group 1: Financial Performance - The projected net profit attributable to shareholders for 2025 is expected to be between 90 million and 135 million yuan, indicating a substantial year-on-year reduction [1] - The company anticipates a net profit excluding non-recurring losses to be between -450 million and -400 million yuan, reflecting a reduction in losses of 62.58% to 66.74% year-on-year [1] Group 2: Reasons for Performance Changes - The company has undergone bankruptcy reorganization, leading to a significant reduction in debt and interest expenses compared to the previous year [1] - Some idle assets have been divested, and the company is in the process of resuming operations at its pig farms, with a rapid recovery in the breeding stock and improved production performance [1] - The current year marks the first year post-reorganization, with some assets still not operational, resulting in depreciation and amortization costs of approximately 80 million yuan for the pig farms and feed factories [1] - The company has recognized approximately 200 million yuan in losses related to bad debt provisions and asset impairments for the year [1] - The gains from debt restructuring are expected to decline significantly compared to 2024 [1]